The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) A change version of the DTSQ (DTSQc) is compared here with the original status. as measured by the Diabetes Treatment Satisfaction Questionnaire (DTSQ status) Principal components analysis was conducted on the 8-item DTSQ (1). Bradley C. Diabetes Treatment Satisfaction Questionnaire (DTSQ). In: Bradley C, ed. Handbook of psychology and diabetes. Chur (Switzerland): Harwood.
| Author: |
Fenrizahn Gujora |
| Country: |
Japan |
| Language: |
English (Spanish) |
| Genre: |
Technology |
| Published (Last): |
9 August 2017 |
| Pages: |
298 |
| PDF File Size: |
12.93 Mb |
| ePub File Size: |
13.48 Mb |
| ISBN: |
539-1-96625-208-2 |
| Downloads: |
95060 |
| Price: |
Free* [*Free Regsitration Required] |
| Uploader: |
Tujar |
Rapid-acting insulin analogs have been shown to improve postprandial glycemic excursion and reduce hypoglycemia compared with regular insulin due to their rapid onset of treament [ 12 ]. Well-being and treatment satisfaction in adults with diabetes: The Diabetes Treatment Satisfaction Questionnaire: These results indicate that the assessment of treatment satisfaction with DTSQ may predict dropout from therapy.
As discussed above, DTSQ scores may auestionnaire be affected by various factors, including waiting time and satisfaction with consultation with medical staff.
This is true not only of diabetes trials. Similar patterns of results, showing that the superiority of the change measure was significantly greater when patients scored at or near ceiling at baseline, were obtained for treatment satisfaction in the Type 2 study.
Howorka and colleagues [ 17 ] have already found the German DTSQc to perform well with Austrian patients with type 1 diabetes comparing meal-related insulins.
JS conducted the analyses of the DTSQ data, contributed to reports and papers on the glargine trials, advised on part of these statistical analyses and contributed to the discussion of the responsiveness analyses. The DTSQc performed as intended, showing significantly enhanced responsiveness to improvements in Treatment Satisfaction, particularly among patients At Ceiling at baseline, as well as greater responsiveness to improvements in perceived blood glucose control. These studies suggest that the DTSQc does not simply elicit positive change responses regardless of treatment circumstances, but does genuinely reflect a response to improvements in treatment borne out by experience.
The important differences lie in the wording of the response options and diqbetes, which, in the DTSQc, direct the respondent to compare their experience of the current treatment with their experience of treatment before the study began.
Change version for use alongside status version provides appropriate solution where ceiling effects occur. American Diabetes Association Glycemic Targets: How satisfied are you with your current treatment?
DTSQs and DTSQc – Diabetes Treatment Satisfaction Questionnaire, status and change versions
Table 1 Major questionnaires for PROs used internationally in patients with diabetes. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution CC BY license http: The efficacy of diabetes treatment should not be evaluated solely by HbA1c levels as they should also focus on patient-reported outcomes PROssuch as patient satisfaction, wellbeing and quality of life.
Given the nature of insulin glargine, with its longer action and constant release of insulin without a pronounced peak, achieved with only one daily injection of basal insulin, it was expected that treatment satisfaction would be greater in the insulin glargine group than the NPH questionnwire.
Long-term results of the Kumamoto Study on optimal diabetes control in treeatment 2 diabetic patients. Treatment satisfaction is assessed as the sum of the scores of the six questions on the first factor total score 36with a higher score indicating higher treatment satisfaction.
Table 2 English and German unforced two-factor analyses. However, as the effect sizes based on these ts differ significantly despite the positive correlations, the stated results are conservative. Aseltine and colleagues suggested that status stsq may not be an error-free method of measuring change, because patients’ standards, or the criteria they use to determine their ratings, may change following treatment as their frame of reference may change, so that apparently identical ratings are not, in fact, comparable.
The questionnaires were filled out anonymously and the patients answered rteatment questionnaires in the waiting room outside the examination room.
However, the principal features observed with the Treatment Satisfaction results, such as the main effect of Questionnaire and the interaction between Questionnaire and Floor effect, were observed once again, with the Change version showing greater improvements reductions in Perceived Hyperglycaemia than the Status version, particularly in those already reporting little hyperglycaemia at baseline.
The new Change measure allowed patients equal opportunity for indicating improvement and deterioration. Novel therapeutic options, such as insulin analogs, incretin-based therapy and sodium-glucose cotransporter 2 SGLT2 inhibitors, have been shown to improve patient satisfaction using DTSQ for assessments.
The problem is not unique to the DTSQs. The goal of diabetes treatment is the prevention of the onset and progression of micro- and macrovascular complications as well as the achievement of quality of life QOL and longevity equivalent to people without diabetes. Relationship between treatment satisfaction and intention to drop out in outpatients with type 2 diabetes. On these two items, low scores represent good perceived blood glucose control.
Psychological outcomes after initiation of insulin treatment in patients with type II diabetes [Abstract] Diabetologia. Change in perceived hypoglycaemia Type 1 trial Patients with type 1 diabetes showed an overall reduction in Perceived Hypoglycaemia, sstisfaction those in the insulin glargine group showing a significantly greater reduction. As anticipated, distribution of the raw baseline DTSQs scores was skewed for Treatment Satisfaction and Perceived Hypoglycaemia [ 5 ]; while Perceived Hyperglycaemia scores were normally distributed.
Published online May 9.
Diabetes Treatment Satisfaction Questionnaire, status and change versions (DTSQs and DTSQc)
Harwood Academic Publishers; When using the status measure with people At Flooran increase in Perceived Hypoglycaemia is apparent, while the change version shows reductions i. Published online Oct The wording of the items themselves is the same for both the status and change versions, the small exception being part of the wording of item 7 recommending the treatment.
Handbook of Psychology and Diabetes: Although the skew could be dealt with statistically and the scale adjusted to queestionnaire the majority scoring pattern i. Change in treatment satisfaction Type 1 trial Treatment Satisfaction increased overall in both the insulin glargine and NPH treatment groups, but with a significantly greater increase in the insulin glargine group.
Two multinational, openlabel, randomised-controlled trials one questionmaire patients with type 1 diabetes, the other for type 2 compared new, longer-acting insulin glargine with standard NPH basal insulin. Glucagon-like peptide 1 GLP-1 analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction. Moreover the DTSQc was used in a recent waiting list control trial [ 23 ]: Comparing prospective and retrospective measures of treatment outcomes.
Impact on treatment success, satisfaction, quality of life, and adherence. Howorka et al [ 17 ] found in a crossover study that patients who went back in the second phase from lispro to standard soluble insulin showed a decline in satisfaction on the retrospective measure, indicating that the DTSQc does not always invoke positive responding.
